Skip to main content
. 2017 Oct 31;12:8025–8034. doi: 10.2147/IJN.S146875

Figure 4.

Figure 4

In vitro cell viability of Jurkat cells treated with IRAK/ABT-NP, IRAK1/4 inhibitor alone, ABT-737 alone and combined solution at different concentrations.

Abbreviation: IRAK/ABT-NP, IRAK1/4 inhibitor and ABT-737 co-encapsulated into polyethylene glycol modified poly (lactic-co-glycolic acid) nanoparticles.